Concepedia

Publication | Closed Access

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

57

Citations

0

References

2001

Year

No additional data available for this publication yet. Check back later!